Long noncoding RNAs: a potential novel class of cancer biomarkers - PubMed (original) (raw)
Review
Long noncoding RNAs: a potential novel class of cancer biomarkers
Aliaksandr A Yarmishyn et al. Front Genet. 2015.
Abstract
Long noncoding RNAs (lncRNAs) are a novel class of RNA molecules defined as transcripts longer than 200 nucleotides that lack protein coding potential. They constitute a major, but still poorly characterized part of human transcriptome, however, evidence is growing that they are important regulatory molecules involved in various cellular processes. It is becoming increasingly clear that many lncRNAs are deregulated in cancer and some of them can be important drivers of malignant transformation. On the one hand, some lncRNAs can have highly specific expression in particular types of cancer making them a promising tool for diagnosis. The expression of other lncRNAs can correlate with different pathophysiological features of tumor growth and with patient survival, thus making them convenient biomarkers for prognosis. In this review we outline the current state of knowledge about the fast growing field of application of lncRNAs as tumor biomarkers.
Keywords: biomarkers; cancer; long noncoding RNA.
Figures
FIGURE 1
Model of long noncoding RNA (lncRNA) HOX transcript antisense RNA (HOTAIR) regulating expression of HOX genes in trans. LncRNA HOTAIR transcribed from the HOXC cluster of genes (chr. 2) binds PRC2 complex of polycomb-group of proteins and targets it to the HOXD cluster (chr. 12) leading to H3K27 methylation and silencing of neighboring HOXD genes. This figure is adapted from Rinn et al., 2007.
Similar articles
- Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star.
Xu T, Lin CM, Cheng SQ, Min J, Li L, Meng XM, Huang C, Zhang L, Deng ZY, Li J. Xu T, et al. Mol Cancer. 2018 Jul 23;17(1):103. doi: 10.1186/s12943-018-0852-7. Mol Cancer. 2018. PMID: 30037351 Free PMC article. Review. - Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
Ricciuti B, Mencaroni C, Paglialunga L, Paciullo F, Crinò L, Chiari R, Metro G. Ricciuti B, et al. Med Oncol. 2016 Feb;33(2):18. doi: 10.1007/s12032-016-0731-2. Epub 2016 Jan 19. Med Oncol. 2016. PMID: 26786153 Review. - Long noncoding RNAs: novel insights into gastric cancer.
Fang XY, Pan HF, Leng RX, Ye DQ. Fang XY, et al. Cancer Lett. 2015 Jan 28;356(2 Pt B):357-66. doi: 10.1016/j.canlet.2014.11.005. Epub 2014 Nov 7. Cancer Lett. 2015. PMID: 25444905 Review. - Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES, Böttcher R, Croce CM, Jenster G, Visakorpi T, Calin GA. Martens-Uzunova ES, et al. Eur Urol. 2014 Jun;65(6):1140-51. doi: 10.1016/j.eururo.2013.12.003. Epub 2013 Dec 14. Eur Urol. 2014. PMID: 24373479 Review. - A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.
Malih S, Saidijam M, Malih N. Malih S, et al. Tumour Biol. 2016 Feb;37(2):1479-85. doi: 10.1007/s13277-015-4572-y. Epub 2015 Dec 11. Tumour Biol. 2016. PMID: 26662315 Review.
Cited by
- GLIDR-mediated regulation of tumor malignancy and cisplatin resistance in non-small cell lung cancer via the miR-342-5p/PPARGC1A axis.
Liu R, Wang J, Zhang L, Wang S, Li X, Liu Y, Yu H. Liu R, et al. BMC Cancer. 2024 Sep 10;24(1):1126. doi: 10.1186/s12885-024-12845-y. BMC Cancer. 2024. PMID: 39256686 Free PMC article. - MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.
Yang W, Yu H, Shen Y, Liu Y, Yang Z, Sun T. Yang W, et al. Oncotarget. 2016 Jul 5;7(27):41505-41526. doi: 10.18632/oncotarget.9214. Oncotarget. 2016. PMID: 27166258 Free PMC article. - Prediction of relapse and prognosis by expression levels of long noncoding RNA PEG10 in glioma patients.
Xiao H, Ding N, Liao H, Yao Z, Cheng X, Zhang J, Zhao M. Xiao H, et al. Medicine (Baltimore). 2019 Nov;98(45):e17583. doi: 10.1097/MD.0000000000017583. Medicine (Baltimore). 2019. PMID: 31702614 Free PMC article. - Long non-coding RNA as a potential diagnostic biomarker in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Masrour M, Khanmohammadi S, Fallahtafti P, Rezaei N. Masrour M, et al. PLoS One. 2023 Sep 21;18(9):e0291921. doi: 10.1371/journal.pone.0291921. eCollection 2023. PLoS One. 2023. PMID: 37733767 Free PMC article. - A novel long non-coding RNA SLNCR1 promotes proliferation, migration, and invasion of melanoma via transcriptionally regulating SOX5.
Cong L, Zhao Q, Sun H, Zhou Z, Hu Y, Li C, Hao M, Cong X. Cong L, et al. Cell Death Discov. 2024 Apr 1;10(1):160. doi: 10.1038/s41420-024-01922-7. Cell Death Discov. 2024. PMID: 38561355 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources